Question

48 of 50
a client with chronic kidney disease (ckd) has been on dialysis for 3 years. the client is receiving the usual combination of medications for the disease, including aluminum hydroxide as a phosphate - binding agent. the client now presents with mental cloudiness, dementia, and complains of bone pain. the nurse determines that these assessment data are compatible with which condition?
answer options
1 advancing uremia
2 phosphate overdose
3 folic acid deficiency
4 aluminum intoxication
rationale, strategy, tip

Explanation:

The client has CKD on dialysis and takes aluminum hydroxide (a phosphate - binder). Aluminum hydroxide can lead to aluminum accumulation. Symptoms like mental cloudiness, dementia, and bone pain are consistent with aluminum intoxication. Advancing uremia has more generalized uremic symptoms, phosphate overdose would have different manifestations (e.g., hyperphosphatemia - related issues like calcification), and folic acid deficiency doesn't cause these symptoms.

Answer:

1. Aluminum intoxication